Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Acelyrin Inc (SLRN)
Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 731,989
  • Shares Outstanding, K 97,339
  • Annual Sales, $ 0 K
  • Annual Income, $ -64,770 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.01
Trade SLRN with:

Options Overview Details

View History
  • Implied Volatility 140.39% ( -3.32%)
  • Historical Volatility 70.92%
  • IV Percentile 74%
  • IV Rank 39.90%
  • IV High 258.37% on 09/05/23
  • IV Low 62.06% on 10/13/23
  • Put/Call Vol Ratio 0.05
  • Today's Volume 22
  • Volume Avg (30-Day) 876
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 9,927
  • Open Int (30-Day) 14,099

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -1.00
  • Number of Estimates 5
  • High Estimate -0.78
  • Low Estimate -1.23
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.76 +10.50%
on 01/24/24
8.72 -14.32%
on 02/20/24
+0.60 (+8.73%)
since 01/23/24
3-Month
5.70 +31.05%
on 01/19/24
8.86 -15.69%
on 11/27/23
-1.02 (-12.01%)
since 11/22/23

Most Recent Stories

More News
Acelyrin (SLRN) Q3 2023 Earnings Call Transcript

SLRN earnings call for the period ending September 30, 2023.

SLRN : 7.48 (-0.53%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acelyrin, Inc. - SLRN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Acelyrin, Inc. ("Acelyrin" or the "Company") (NASDAQ: SLRN). Such investors are...

SLRN : 7.48 (-0.53%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acelyrin, Inc. - SLRN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Acelyrin, Inc. ("Acelyrin" or the "Company") (NASDAQ: SLRN). Such investors are...

SLRN : 7.48 (-0.53%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acelyrin, Inc. - SLRN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Acelyrin, Inc. ("Acelyrin" or the "Company") (NASDAQ: SLRN). Such investors are...

SLRN : 7.48 (-0.53%)
Why Acelyrin Stock Plummeted 59% This Week

The recently public biopharma company announced disappointing results from a clinical trial of its lead drug candidate.

SLRN : 7.48 (-0.53%)
Stocks Retreat as Tech Stocks Fall on Weakness in Oracle and Apple

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.57%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 5,097.81 (+0.21%)
SPY : 508.92 (+0.28%)
$DOWI : 39,181.90 (+0.29%)
DIA : 391.83 (+0.33%)
$IUXX : 18,002.32 (-0.01%)
QQQ : 438.35 (+0.06%)
ORCL : 111.87 (+0.77%)
NTRS : 81.39 (+1.76%)
ETN : 285.67 (+0.38%)
AAPL : 182.90 (-0.80%)
SLRN : 7.48 (-0.53%)
CMA : 49.55 (-0.82%)
Why Shares of MoonLake Immunotherapeutics Are Rising Tuesday

A competitor's clinical trial stumble may be benefiting MoonLake.

SLRN : 7.48 (-0.53%)
MLTX : 52.90 (+1.32%)
Plunge in Oracle Weighs on Tech Stocks and Overall Market

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.60%....

$SPX : 5,097.81 (+0.21%)
SPY : 508.92 (+0.28%)
$DOWI : 39,181.90 (+0.29%)
DIA : 391.83 (+0.33%)
$IUXX : 18,002.32 (-0.01%)
QQQ : 438.35 (+0.06%)
ORCL : 111.87 (+0.77%)
NTRS : 81.39 (+1.76%)
RTX : 90.05 (+0.58%)
AER : 78.95 (+0.48%)
AAPL : 182.90 (-0.80%)
SLRN : 7.48 (-0.53%)
Markets Today: Stock Index Futures Slide as Oracle Plunges on Disappointing Cloud Sales

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are down -0.22%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are down -0.30%. Stock index futures this morning are mildly lower. Weakness...

ESH24 : 5,110.00 (+0.24%)
NQH24 : 18,055.25 (+0.04%)
ORCL : 111.87 (+0.77%)
UPS : 149.78 (+0.03%)
RTX : 90.05 (+0.58%)
AER : 78.95 (+0.48%)
SLRN : 7.48 (-0.53%)
WRK : 43.86 (-0.18%)
PARA : 11.25 (-3.93%)
CVS : 77.01 (-0.12%)
Stock Index Futures Slip as Investors Brace for U.S. Inflation Data, Oracle Results Disappoint

September S&P 500 futures (ESU23) are down -0.23%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.26% this morning as market participants exercised caution and refrained from taking big positions...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
TSLA : 193.88 (-1.79%)
QCOM : 155.41 (+0.43%)
TWNK : 33.30 (-0.15%)
RTX : 90.05 (+0.58%)
ORCL : 111.87 (+0.77%)
ABF.LN : 2,291.000 (-0.09%)
SGHT : 4.44 (+3.26%)
SLRN : 7.48 (-0.53%)
GERN : 1.9900 (+1.02%)
AER : 78.95 (+0.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Acelyrin Inc. is a clinical biopharma company. It focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep. Acelyrin Inc. is based in Agoura Hills, California.

See More

Key Turning Points

3rd Resistance Point 8.13
2nd Resistance Point 7.97
1st Resistance Point 7.75
Last Price 7.48
1st Support Level 7.37
2nd Support Level 7.21
3rd Support Level 6.99

See More

52-Week High 29.88
Fibonacci 61.8% 20.64
Fibonacci 50% 17.79
Fibonacci 38.2% 14.94
Last Price 7.48
52-Week Low 5.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar